22
Participants
Start Date
October 10, 2019
Primary Completion Date
June 19, 2023
Study Completion Date
May 31, 2025
Cabazitaxel
20 mg/m2 Q 21 days
Carboplatin
AUC 4 Q21 Days x 6 cycles with ADT
Abiraterone
1000 mg PO daily
Prednisone
5 mg PO daily on chemotherapy completion
Thomas Jeferson University, Philadelphia
Masonic Cancer Center at University of Minnesota, Minneapolis
Northwestern University, Chicago
University of Chicago, Chicago
Tulane University, New Orleans
Mayo Clinic Arizona, Phoenix
Comprehensive Cancer Centers of Nevada, Las Vegas
Lifespan Cancer Institute, Providence
Masonic Cancer Center, University of Minnesota
OTHER